Clinical Trial: A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828120) titled 'A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects' on Feb. 10.

Brief Summary: To evaluate the safety and efficacy of Taneasy 600mg granules and Fluimucil 600mg granules administered twice daily for 14 days in treatment of COPD Disease.

Study Start Date: Feb. 20

Study Type: INTERVENTIONAL

Condition: COPD (Chronic Obstructive Pulmonary Disease)

Intervention: DRUG: Taneasy 600mg granules

Treatment of respiratory affections characterized by thick and viscous hypersecretion due to acute bronchitis,chronic bronchitis and its exacerbation, plumonary emphysema,mucoviscidos...